Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 811: Which statement is not true regarding cross-sectional studies?

A. Prevalence can be measured.
B. Does not provide information about incidence.
C. Is less expensive compared to longitudinal studies.
D. Is useful for studying acute diseases. (Correct Answer)

Explanation: **Explanation:** **1. Why Option D is the correct (False) statement:** Cross-sectional studies are often referred to as **"Prevalence Studies"** or "Snapshot Studies." They measure the exposure and outcome simultaneously at a single point in time. Because they capture only a "snapshot," they are unsuitable for studying **acute diseases** (diseases with short durations, like the common cold or cholera). By the time a cross-sectional survey is conducted, patients with acute illnesses have either recovered or succumbed, making them unlikely to be captured in the sample. These studies are best suited for **chronic conditions** (e.g., Hypertension, Diabetes) where the disease persists over time. **2. Analysis of Incorrect Options:** * **Option A (True):** Since the study identifies all existing cases at a specific point in time, it directly measures **Prevalence**. * **Option B (True):** Incidence refers to *new* cases occurring over a period. Since there is no follow-up (temporal dimension) in a cross-sectional design, it **cannot measure incidence**. * **Option C (True):** Because there is no long-term follow-up or repeated visits (unlike longitudinal/cohort studies), cross-sectional studies are significantly **faster and less expensive**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Temporal Ambiguity:** The biggest limitation of cross-sectional studies is the "chicken or egg" dilemma—it is impossible to determine if the exposure preceded the outcome. * **Neyman Bias (Prevalence-Incidence Bias):** Cross-sectional studies over-represent chronic/stable cases and under-represent acute/fatal cases. * **Sequence of Study Designs:** Often used as the first step in investigating an association before progressing to Case-Control or Cohort studies.

Question 812: In a population of 5000, the incidence of a disease is 100 cases in 1 year. The duration of the disease studied is 2 years. Calculate the prevalence.

A. 20/1000
B. 40/1000 (Correct Answer)
C. 80/1000
D. 400/1000

Explanation: ### **Explanation** The core concept tested here is the mathematical relationship between **Incidence, Prevalence, and Duration** of a disease. #### **1. Why Option B is Correct** For stable diseases with low frequency, the relationship is expressed by the formula: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D)** * **Step 1: Calculate Incidence (I)** Incidence = (New cases / Total population) = 100 / 5,000. * **Step 2: Identify Duration (D)** Duration = 2 years. * **Step 3: Apply the Formula** P = (100 / 5,000) × 2 P = 200 / 5,000 P = 40 / 1,000 Thus, the prevalence is **40 per 1,000 population**. #### **2. Why Other Options are Incorrect** * **Option A (20/1000):** This represents only the annual incidence (100/5000). It fails to account for the 2-year duration during which cases accumulate. * **Option C (80/1000):** This is a calculation error, likely from doubling the correct prevalence or misapplying the denominator. * **Option D (400/1000):** This is a decimal error (off by a factor of 10), representing a 40% prevalence, which is inconsistent with the data provided. #### **3. NEET-PG High-Yield Pearls** * **Definitions:** Incidence measures **new cases** (indicator of risk/etiology); Prevalence measures **all current cases** (indicator of burden/administrative planning). * **Factors increasing Prevalence:** Longer duration of disease, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Factors decreasing Prevalence:** Shorter duration, high case fatality rate, improved cure rate, and out-migration. * **Rule of Thumb:** If a disease is highly fatal or easily cured, its prevalence will be low even if the incidence is high.

Question 813: Which of the following is NOT an example of a disease exhibiting a cyclical trend of occurrence?

A. Measles
B. Rubella
C. Influenza
D. Polio (Correct Answer)

Explanation: ### Explanation In epidemiology, **cyclical trends** refer to the recurrent fluctuations in disease incidence over short periods (usually 2–3 years or more). These cycles are typically driven by the buildup of a critical mass of susceptible individuals in a population (herd immunity threshold). **Why Polio is the Correct Answer:** Polio does not exhibit a cyclical trend; instead, it follows a **seasonal trend**. Historically, polio incidence peaked during the summer and early autumn months in temperate climates. Furthermore, due to the Global Polio Eradication Initiative and intensive vaccination (Pulse Polio), the natural transmission cycles have been disrupted, moving the disease toward elimination rather than periodic cycles. **Analysis of Incorrect Options:** * **Measles:** Classically exhibits a 2–3 year cycle in the pre-vaccination era. As new births occur, the pool of susceptible children grows until it reaches a threshold that triggers an epidemic. * **Rubella:** Historically shows a cyclical pattern every 6–9 years. Like measles, it depends on the accumulation of non-immune individuals. * **Influenza:** Exhibits both seasonal trends (annual winter peaks) and cyclical trends (pandemics occurring every 10–40 years due to major antigenic shifts). **High-Yield NEET-PG Pearls:** * **Secular Trend:** Long-term changes (years/decades) in disease occurrence (e.g., the rise of Diabetes or the decline of TB). * **Cyclical Trend:** Short-term periodic fluctuations (e.g., Measles: 2–3 years; Rubella: 6–9 years). * **Seasonal Trend:** Fluctuations within a single year (e.g., GI infections in summer, Respiratory infections in winter). * **Point Source Epidemic:** All cases occur within one incubation period (e.g., Food poisoning).

Question 814: In which year was the first reliable census conducted in India?

A. 1881 (Correct Answer)
B. 1951
C. 1981
D. 2001

Explanation: ### Explanation **1. Why Option A is Correct:** The first **synchronous (reliable and complete)** census in India was conducted in **1881** under the British administration (Lord Ripon). While an initial attempt at a census was made in 1872 (under Lord Mayo), it was non-synchronous and did not cover the entire country simultaneously. The 1881 census established the standard for the decennial (every 10 years) census system that continues today, making it the benchmark for reliable demographic data collection in India. **2. Why Other Options are Incorrect:** * **Option B (1951):** This was the **first census of Independent India**. It is significant for post-independence planning but not the "first reliable" one in historical terms. * **Option C (1981):** This was the 12th census in the series. It is notable for being the first to include questions on "reasons for migration," but it holds no "first" status regarding reliability. * **Option D (2001):** This was the first census of the 21st century. It is historically distant from the origin of the Indian census system. **3. High-Yield Facts for NEET-PG:** * **Census Frequency:** Conducted every **10 years** (Decennial) under the Census Act, 1948. * **The "Great Divide":** The year **1921** is known as the "Year of the Great Divide" because it was the only census year where India recorded a negative population growth rate. * **Census Method:** India primarily uses the **"Extended De Facto"** method (canvassing over a period, with a reference date). * **Authority:** The census is conducted by the **Registrar General and Census Commissioner of India** under the Ministry of Home Affairs. * **2011 Census Fact:** The mascot was a "Female Enumerator," and the slogan was "Our Census, Our Future."

Question 815: Which of the following is an example of primordial prevention?

A. Action taken prior to the onset of disease.
B. Prevention of the emergence or development of risk factors. (Correct Answer)
C. Action taken to remove the possibility that a disease will ever occur.
D. Action that halts the progress of a disease.

Explanation: ### Explanation **1. Why Option B is Correct:** Primordial prevention is a relatively modern concept in epidemiology that focuses on preventing the **emergence or development of risk factors** in population groups where they have not yet appeared. It targets the underlying social, economic, and environmental patterns of living (e.g., discouraging children from starting smoking or promoting physical activity to prevent obesity). It is the "prevention of risk factors" itself, rather than the prevention of disease in the presence of risk factors. **2. Analysis of Incorrect Options:** * **Option A (Action taken prior to onset of disease):** This is the general definition of **Primary Prevention**. While primordial prevention also occurs before disease onset, primary prevention specifically aims to reduce the incidence of disease by addressing risk factors that *already exist* (e.g., using a seatbelt or immunization). * **Option C (Action to remove the possibility that a disease will ever occur):** This describes the goal of **Primary Prevention** (specifically health promotion and specific protection) or, in a broader sense, **Eradication**. * **Option D (Action that halts the progress of a disease):** This defines **Secondary Prevention**. It involves early diagnosis and prompt treatment to stop the progression of a disease and prevent complications (e.g., Pap smear for cervical cancer). **3. NEET-PG High-Yield Pearls:** * **Target Audience:** Primordial prevention is primarily delivered through **individual and mass education**. * **Classic Example:** Changing dietary patterns in a country to prevent a future epidemic of hypertension or CAD. * **The "Four Levels" Hierarchy:** 1. **Primordial:** Prevent emergence of risk factors. 2. **Primary:** Action in the "Pre-pathogenesis" phase (Risk factor present). 3. **Secondary:** Action in the "Early pathogenesis" phase (Early diagnosis). 4. **Tertiary:** Action in the "Late pathogenesis" phase (Disability limitation and Rehabilitation).

Question 816: In a study of 500 patients with viral fever, 80 percent were cured within 3 days after receiving a certain medicine. Which statement accurately reflects the efficacy of this medicine based on this data?

A. The medicine is definitively effective.
B. The efficacy of the medicine cannot be definitively commented on. (Correct Answer)
C. The medicine is ineffective.
D. None of the above.

Explanation: ### Explanation **1. Why the Correct Answer is Right (Option B)** The core epidemiological concept here is the **absence of a Control Group**. To determine the efficacy of a drug, a study must compare the outcomes of a treatment group against a control group (either a placebo or standard care). In this scenario, while 80% of patients recovered, we do not know the **natural history** of the viral fever. Many viral illnesses are self-limiting and might resolve within 3 days without any intervention. Without a control group, we cannot distinguish between the **drug effect** and the **spontaneous recovery rate**. Therefore, the efficacy remains "not definitively commented on." **2. Why the Incorrect Options are Wrong** * **Option A:** Claiming the medicine is "definitively effective" is a logical fallacy known as *post hoc ergo propter hoc* (after this, therefore because of this). Without a baseline comparison, the 80% cure rate could simply be the natural recovery rate of the disease. * **Option C:** We cannot label the medicine "ineffective" either. It might indeed be highly potent, but the study design (a simple case series/descriptive study) lacks the analytical power to prove it. **3. NEET-PG High-Yield Pearls** * **Gold Standard for Efficacy:** The **Randomized Controlled Trial (RCT)** is the best study design to establish the efficacy of a new drug because randomization eliminates confounding bias. * **Observational vs. Analytical:** This study is a **Case Series** (descriptive). Descriptive studies can generate hypotheses but **cannot** establish a causal relationship or drug efficacy. * **Efficacy vs. Effectiveness:** * *Efficacy:* Performance under ideal, controlled conditions (RCTs). * *Effectiveness:* Performance in real-world "field" conditions. * **Control Groups:** They are essential to account for the **Placebo Effect**, **Hawthorne Effect**, and **Natural progression** of the disease.

Question 817: Which of the following are included in the surveillance definition for AIDS?

A. Extrapulmonary TB, Cryptococcosis, Candidiasis, Leptospirosis
B. Extrapulmonary TB, Cryptococcosis, Candidiasis, Kaposi sarcoma (Correct Answer)
C. Extrapulmonary TB, Candidiasis, Leptospirosis, Kaposi sarcoma
D. Extrapulmonary TB, Cryptococcosis, Leptospirosis, Kaposi sarcoma

Explanation: ### Explanation The surveillance definition for AIDS is based on the presence of specific **AIDS-defining illnesses** (opportunistic infections and malignancies) in an individual with HIV infection. These conditions typically manifest when the CD4+ T-cell count drops below 200 cells/mm³. **1. Why Option B is Correct:** The conditions listed in Option B are classic AIDS-defining illnesses recognized by the WHO and NACO: * **Extrapulmonary Tuberculosis:** While pulmonary TB is common, the spread to extrapulmonary sites (miliary, lymph nodes, etc.) is a hallmark of advanced immunosuppression. * **Cryptococcosis:** Specifically extrapulmonary cryptococcosis (e.g., Cryptococcal meningitis). * **Candidiasis:** Specifically of the esophagus, trachea, bronchi, or lungs (not just oral thrush). * **Kaposi Sarcoma:** A vascular tumor caused by HHV-8, which is a defining malignancy in HIV patients. **2. Why Other Options are Incorrect:** Options A, C, and D include **Leptospirosis**. Leptospirosis is a zoonotic bacterial infection caused by *Leptospira interrogans*. While it is a significant public health concern in tropical regions, it is **not** an opportunistic infection associated with HIV/AIDS and is not included in the surveillance definition. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common opportunistic infection (OI) in India:** Tuberculosis (both pulmonary and extrapulmonary). * **Most common fungal OI:** Candidiasis (Oral/Esophageal). * **Most common malignancy:** Kaposi Sarcoma (globally), though Non-Hodgkin Lymphoma is also highly prevalent. * **Pneumocystis jirovecii pneumonia (PCP):** Another high-yield AIDS-defining illness; prophylaxis (Cotrimoxazole) is started when CD4 < 200. * **Toxoplasmosis:** Brain abscesses (ring-enhancing lesions) are defining when CD4 < 100.

Question 818: Acute flaccid paralysis is reported in a child aged:

A. 0-3 years
B. 3-5 years
C. 0-15 years (Correct Answer)
D. 15-19 years

Explanation: ### Explanation **1. Why 0-15 years is the Correct Answer:** Under the **Global Polio Eradication Initiative**, Acute Flaccid Paralysis (AFP) surveillance is the gold standard for detecting cases of poliomyelitis. The operational definition for AFP surveillance includes any child **under 15 years of age** who presents with a sudden onset of flaccid weakness or paralysis. This age group is targeted because children under 15 are biologically most susceptible to paralytic poliomyelitis. Additionally, any person of any age must be reported if a clinician strongly suspects polio. **2. Analysis of Incorrect Options:** * **A (0-3 years) & B (3-5 years):** While younger children are at the highest risk for contracting polio (often called "infantile paralysis"), limiting surveillance to these ages would result in missing a significant number of cases in older children, thereby failing to detect circulating poliovirus in the community. * **D (15-19 years):** While adolescents can technically contract polio, they are not the primary target for routine AFP surveillance protocols unless there is a high clinical suspicion. **3. NEET-PG High-Yield Clinical Pearls:** * **AFP Surveillance Criteria:** A sensitive surveillance system must detect at least **3 cases of non-polio AFP per 100,000 children** under 15 years of age annually (in India). * **Specimen Collection:** To confirm or rule out polio, **two "adequate" stool samples** must be collected 24–48 hours apart, within 14 days of the onset of paralysis. * **The "60-Day" Rule:** All AFP cases must be followed up at 60 days from the onset of paralysis to check for residual paralysis, which is a hallmark of paralytic polio. * **Differential Diagnosis for AFP:** The most common cause of non-polio AFP is **Guillain-Barré Syndrome (GBS)**.

Question 819: A new drug does not prevent a disease from occurring but reduces death due to that disease. Which of the following is true?

A. It will increase the incidence and prevalence
B. It will decrease the incidence and prevalence
C. Prevalence is increased (Correct Answer)
D. Incidence is increased

Explanation: ### Explanation This question tests the fundamental understanding of the relationship between **Incidence**, **Prevalence**, and **Disease Duration**. #### 1. Why the Correct Answer is Right The core concept here is the formula: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D)**. * **Incidence** refers only to *new* cases. Since the drug does not prevent the disease from occurring, the rate of new cases remains unchanged. * **Prevalence** refers to *all* existing cases (new + old) at a given time. * By reducing deaths, the drug ensures that patients live longer with the disease. This increases the **duration (D)** of the illness. As patients stay in the "prevalent pool" longer instead of leaving it through death, the total number of existing cases (**Prevalence**) increases. #### 2. Why Other Options are Wrong * **Option A & D (Incidence is increased):** Incidence is affected by preventive measures (vaccines, lifestyle changes). Since this drug is a treatment that doesn't prevent occurrence, it has no impact on the number of new cases. * **Option B (Decrease incidence and prevalence):** This would only happen if the drug was a primary preventive measure (decreasing incidence) or a rapid cure (decreasing duration/prevalence). #### 3. High-Yield Clinical Pearls for NEET-PG * **Prevalence** is increased by: Longer duration of disease, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Prevalence** is decreased by: Shorter duration of disease, high case fatality rate (death), rapid cure, and out-migration of cases. * **Incidence** is the best indicator for **etiology** (causation) and the effectiveness of **primary prevention**. * **Prevalence** is most useful for **administrative purposes** and healthcare planning (e.g., estimating the number of hospital beds needed).

Question 820: In a case-control study, how is the association between a disease and a risk factor primarily assessed?

A. Relative risk
B. Attributable risk
C. Population attributable risk
D. Odds ratio (Correct Answer)

Explanation: ### Explanation In epidemiology, the choice of association measure depends entirely on the study design. **Why Odds Ratio (OR) is correct:** A **Case-Control study** starts with the outcome (disease) and looks backward to determine exposure. Because the researcher determines the number of cases and controls at the start, the true **incidence** of the disease cannot be calculated. Since Relative Risk requires incidence data, it cannot be used. Instead, we use the **Odds Ratio**, which estimates the odds of exposure among cases compared to the odds of exposure among controls. It serves as a reliable proxy for Relative Risk when the disease is rare. **Why other options are incorrect:** * **A. Relative Risk (RR):** This is the primary measure for **Cohort studies**. It requires the calculation of incidence (new cases over time), which is only possible in prospective designs where we follow exposed and non-exposed groups. * **B. Attributable Risk (AR):** This measures the amount of disease incidence that can be attributed to a specific exposure. Like RR, it requires **incidence rates** from a cohort study. * **C. Population Attributable Risk (PAR):** This indicates how much of the disease in the total population would be eliminated if the exposure were removed. It also relies on incidence data. **High-Yield Clinical Pearls for NEET-PG:** * **Case-Control Study:** Retrospective, fast, inexpensive, and ideal for **rare diseases**. * **Cohort Study:** Prospective, expensive, time-consuming, and ideal for **rare exposures**. * **Odds Ratio Formula:** $ad / bc$ (Cross-product ratio from a 2x2 table). * **Matching:** A technique used in Case-Control studies to eliminate **confounding bias**. * **Recall Bias:** The most common type of bias encountered in Case-Control studies.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free